Merck KGaA Profit Beats Estimates on Cost-Cutting

May 14 (Bloomberg) -- Merck KGaA, the German maker of cancer drug Erbitux, said first-quarter profit rose on higher-than-expected savings from a reorganization program, and forecast it will achieve 2014 targets a year ahead of schedule. Mark Barton reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
MasterCard Is an Enabler for Financial Inclusion: Driver
13:07 - MasterCard Southeast Asia President Matthew Driver discusses financial inclusion, technology’s role in breaking down the barriers and his company’s growth strategy in Asia. He speaks to Bloomberg’s Haslinda Amin at the World Economic Forum in Jakarta, Indonesia. (Source: Bloomberg)
  • ECB's Draghi's Comments on Greece in Two Minutes
  • ECB's Draghi News Conf.: Greece, Europe Economy
  • Momentum Adventure Offers $1M Trip of a Lifetime